Bachet J, Goudot B, Dreyfus G D, Brodaty D, Dubois C, Delentdecker P, Guilmet D
Service de Chirurgie Cardio-Vasculaire, Hopital Foch, Université René Descartes, Suresnes, France.
Ann Thorac Surg. 1999 Jun;67(6):2006-9; discussion 2014-9. doi: 10.1016/s0003-4975(99)00433-6.
In 1977, we proposed the use of gelatin-resorcinol-formol (GRF) biological glue during surgery for acute type A aortic dissection.
From January 1977 to March 1998, 204 patients (146 men and 58 women) aged from 15 to 79 years (mean 54 +/- 11) underwent emergency operation for type A aortic dissection in our institution. One hundred sixty-five patients (84%) were operated on within 48 h after the onset of symptoms. Twenty-eight patients (13.7%) had Marfan's syndrome. In 43 patients (23%), the aortic valve was replaced either independently (6, 3%) or by means of a composite graft (37, 18.1%). Because of the location of the intimal tear, aortic replacement included the transverse arch in 60 patients (29.4%).
Hospital mortality was 21% (39 patients): 25% in patients with arch replacement and 19.4% in patients without arch replacement (ns). One hundred sixty-one patients were discharged and followed from 2 months to 21 years postoperatively (mean 85 +/- 66 months). During this interval, 25 patients (15.5%) required reoperation for a total of 33 reoperations. Seven patients (28%) died at reoperation. Upon univariate analysis, presence of Marfan's syndrome (p < 0.05) and absence of arch replacement (p < 0.02) were risk factors for reoperation. Emergency operation (p < 0.01) and thoracoabdominal replacement (p < 0.04) were risk factors for death at reoperation. The actuarial freedom from reoperation (Kaplan-Meier, confidence interval 95%) is 96.1% (90.9%-98.2%) at 1 year, 87.6% (79.8%-92.7%) at 5 years, 80.9% (70.8%-88.1%) at 10 years, and 66.4% (51.1%-78.9%) at 15 years. A total of 39 patients (24.3%) died during follow-up. The presence of Marfan's syndrome (p < 0.01), reoperation (p < 0.02), stroke (p < 0.05), and cardiac failure (p < 0.05) were risk factors for late mortality. The actuarial late survival including hospital mortality is 71.5% (64.3%-77.8%) at 1 year, 66% (58.3%-73%) at 5 years, 56.4% (47.7%-64.7%) at 10 years, and 46.3% (36.4%-56.5%) at 15 years.
The GRF glue has proven extremely useful during emergency initial surgery for acute type A dissection, making the procedure much easier and safer. As a result of this operative improvement, the use of the GRF glue seems to have had a beneficial influence on late results, but these also depend upon the patient's basic condition.
1977年,我们提议在急性A型主动脉夹层手术中使用明胶-间苯二酚-甲醛(GRF)生物胶。
1977年1月至1998年3月,我院对204例年龄在15至79岁(平均54±11岁)的患者(146例男性和58例女性)进行了急性A型主动脉夹层急诊手术。165例患者(84%)在症状发作后48小时内接受手术。28例患者(13.7%)患有马凡综合征。43例患者(23%)单独(6例,3%)或通过复合移植物(37例,18.1%)置换了主动脉瓣。由于内膜撕裂的位置,60例患者(29.4%)的主动脉置换包括横弓。
医院死亡率为21%(39例患者):行弓部置换的患者死亡率为25%,未行弓部置换的患者死亡率为19.4%(无统计学差异)。161例患者出院后接受了术后2个月至21年(平均85±66个月)的随访。在此期间,25例患者(15.5%)因总共33次再次手术而需要再次手术。7例患者(28%)在再次手术时死亡。单因素分析显示,马凡综合征的存在(p<0.05)和未行弓部置换(p<0.02)是再次手术的危险因素。急诊手术(p<0.01)和胸腹联合置换(p<0.04)是再次手术时死亡的危险因素。1年时再次手术的精算自由度(Kaplan-Meier法,95%置信区间)为9,6.1%(90.9%-98.2%),5年时为87.6%(79.8%-92.7%),10年时为80.9%(70.8%-88.1%),15年时为66.4%(51.1%-78.9%)。共有39例患者(24.3%)在随访期间死亡。马凡综合征的存在(p<0.01)、再次手术(p<0.02)、中风(p<0.05)和心力衰竭(p<0.05)是晚期死亡的危险因素。包括医院死亡率在内的精算晚期生存率1年时为71.5%(64.3%-77.8%),5年时为66%(58.3%-73%),10年时为56.4%(47.7%-64.7%),15年时为46.3%(36.4%-56.5%)。
GRF胶在急性A型夹层的急诊初次手术中已被证明非常有用,使手术更加简便和安全。由于这种手术改进,GRF胶的使用似乎对晚期结果产生了有益影响,但这些结果也取决于患者的基础状况。